MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
8.63
-0.37 (-4.11%)
At close: Dec 30, 2025, 4:00 PM EST
8.50
-0.13 (-1.51%)
After-hours: Dec 30, 2025, 7:11 PM EST
MetaVia Market Cap
MetaVia has a market cap or net worth of $19 million as of December 30, 2025. Its market cap has decreased by -4.34% in one year.
Market Cap
19.00M
Enterprise Value
4.79M
1-Year Change
-4.34%
Ranking
Category
Stock Price
$8.63
Market Cap Chart
Since December 31, 2019, MetaVia's market cap has decreased from $104.41B to $19.00M, a decrease of -99.98%. That is a compound annual growth rate of -76.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 19.00M | 8.62% |
| Dec 31, 2024 | 17.49M | -2.47% |
| Dec 29, 2023 | 17.93M | 31.75% |
| Dec 30, 2022 | 13.61M | -58.04% |
| Dec 31, 2021 | 32.44M | -62.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |